SEC Form 4 · accession 0001179110-18-005585
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Todd A Trapp
Officer — Vice President, CFO
Period of report
Apr 9, 2018
Accepted (ET)
Apr 11, 2018 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1 | Apr 9, 2018 | A | 6,288 | $0.00 | A | 6,288 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of April 9, 2019, April 9, 2020 and April 9, 2021, so long as the reporting person continues to be employed by the issuer on the vesting dates.